These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 20187020)

  • 1. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials.
    Matcham J; Julious S; Pyke S; O'Kelly M; Todd S; Seldrup J; Day S
    Pharm Stat; 2011; 10(1):70-3. PubMed ID: 20187020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics.
    Campbell MJ
    Pharm Stat; 2011; 10(1):80-1. PubMed ID: 21275038
    [No Abstract]   [Full Text] [Related]  

  • 3. The potential for bias in reporting of industry-sponsored clinical trials.
    Pyke S; Julious SA; Day S; O'Kelly M; Todd S; Matcham J; Seldrup J
    Pharm Stat; 2011; 10(1):74-9. PubMed ID: 21275037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Industry sponsorship and authorship of clinical trials over 20 years.
    Buchkowsky SS; Jewesson PJ
    Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective.
    Mansi BA; Clark J; David FS; Gesell TM; Glasser S; Gonzalez J; Haller DG; Laine C; Miller CL; Mooney LA; Zecevic M
    Mayo Clin Proc; 2012 May; 87(5):424-9. PubMed ID: 22560521
    [No Abstract]   [Full Text] [Related]  

  • 6. Industry sponsorship in research and publishing: who is really to blame for perceived bias?
    Amsden GW
    Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974
    [No Abstract]   [Full Text] [Related]  

  • 7. [Publication ethics: regulation of financial conflicts of interests in medical journals].
    Kakuk P
    Lege Artis Med; 2011 Jan; 21(1):65-71. PubMed ID: 21469379
    [No Abstract]   [Full Text] [Related]  

  • 8. Disclosure of competing financial interests and role of sponsors in phase III cancer trials.
    Tuech JJ; Moutel G; Pessaux P; Thoma V; Schraub S; Herve C
    Eur J Cancer; 2005 Oct; 41(15):2237-40. PubMed ID: 16214044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making available information from studies sponsored by the pharmaceutical industry: some current practices.
    O'Kelly M; Julious SA; Pyke S; Day S; Todd S; Seldrup J; Matcham J
    Pharm Stat; 2011; 10(1):60-9. PubMed ID: 21275036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How pharmaceutical industry funding affects trial outcomes: causal structures and responses.
    Sismondo S
    Soc Sci Med; 2008 May; 66(9):1909-14. PubMed ID: 18299169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research dishonesty and conflict of interest.
    Frizelle F
    N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259
    [No Abstract]   [Full Text] [Related]  

  • 12. Commentary.
    Snapinn S
    Pharm Stat; 2011; 10(1):83-4. PubMed ID: 21275040
    [No Abstract]   [Full Text] [Related]  

  • 13. [The roles and responsibilities of the pharmaceutical industry].
    Dejgaard A; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Industry funding and author-industry affiliation in clinical trials in psychiatry.
    Montgomery JH
    Am J Psychiatry; 2006 Jun; 163(6):1110-1; author reply 1111. PubMed ID: 16741218
    [No Abstract]   [Full Text] [Related]  

  • 15. Control of data, authorship, and responsibility for clinical trials publications.
    Freeman WR
    Ophthalmology; 2005 Sep; 112(9):1485-6. PubMed ID: 16139664
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluating solutions to sponsorship bias.
    Doucet M; Sismondo S
    J Med Ethics; 2008 Aug; 34(8):627-30. PubMed ID: 18667655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uneasy alliance--clinical investigators and the pharmaceutical industry.
    Bodenheimer T
    N Engl J Med; 2000 May; 342(20):1539-44. PubMed ID: 10816196
    [No Abstract]   [Full Text] [Related]  

  • 18. [More stringent requirements concerning manuscripts. Declarations of potential connections and conflicts of interest published in the Lakartidningen].
    Milerad J; Ahlberg J; Eliasson M; Fridén B; Håkansson A; Sundberg CJ; Agren H; Ostergren J
    Lakartidningen; 2002 Apr; 99(15):1662-3. PubMed ID: 12025190
    [No Abstract]   [Full Text] [Related]  

  • 19. Conflicts of interest in dermatology.
    Williams HC; Naldi L; Paul C; Vahlquist A; Schroter S; Jobling R
    Acta Derm Venereol; 2006; 86(6):485-97. PubMed ID: 17106594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conflicts of interest--an evidence-based approach].
    Slørdal L; Eggen AE; Rygnestad T
    Tidsskr Nor Laegeforen; 2012 Jun; 132(11):1358-60. PubMed ID: 22717864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.